文献速递心血管胸部CT

稳定胸痛患者推迟心脏检查的不同策略比较

Comparison of Different Investigation Strategies to Defer Cardiac Testing in Patients With Stable Chest Pain.
PubMed 文献 · JACC Cardiovasc Imaging · 2021-10-13

研究纳入4207例因稳定胸痛转诊行冠状动脉CT血管造影的患者,比较5种策略(NICE、PROMISE、ESC、CACS、CACS-CL)将患者分为低危组的能力。CACS-CL策略低危组比例最高(51.41%),且风险组与阻塞性冠心病、主要不良心血管事件及后续强化临床管理的关联最强,诊断准确性与阳性净重分类改善也更好。

要点

  • CACS-CL策略将51.41%患者归为低危,为5种策略中比例最高。
  • CACS-CL策略风险组与阻塞性冠心病的OR为16.00,高于其他策略。
  • CACS-CL策略风险组与主要不良心血管事件的HR为6.83,高于其他策略。

核心结论

  • 在当代用于识别稳定胸痛低危患者的策略中,CACS尤其是结合临床风险特征的CACS-CL策略,显示出最强的有效推迟心脏检查的潜力。

研究设计与样本

  • 共4207例因稳定胸痛转诊行冠状动脉CT血管造影的患者,按2016 NICE指南策略、PROMISE最小风险工具策略、2019 ESC指南策略、CACS策略及CACS-CL策略分为低危和高危组,评估并比较各策略风险组与阻塞性冠心病、主要不良心血管事件及后续临床管理的关联。

诊断标准与关键数值

  • NICE、PROMISE、ESC、CACS、CACS-CL策略归入低危组的患者比例分别为22.63%、29.21%、41.84%、46.76%、51.41%。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to compare the current 5 investigation strategies to defer cardiac testing in patients with stable chest pain.

BACKGROUND: For the clinical management of stable chest pain, the identification of patients unlikely to benefit from further cardiac testing is important, but the most appropriate investigation strategy is unknown.

METHODS: A total of 4,207 patients referred to coronary computed tomography angiography for stable chest pain were classified into low- and high-risk groups according to the 2016 National Institute of Health and Care Excellence (NICE) guideline-determined strategy; PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) minimal risk tool-based strategy; 2019 European Society of Cardiology (ESC) guideline-determined strategy; and coronary artery calcium score (CACS), either in isolation (the CACS strategy) or as part of a weighted clinical likelihood model-based strategy (the CACS-CL strategy). The associations of obstructive coronary artery disease on coronary computed tomography angiography, major adverse cardiovascular events, and subsequent clinical management with risk groups according to different strategies were evaluated and compared.

RESULTS: The NICE, PROMISE, ESC, CACS, and CACS-CL strategies classified a proportion (22.63%, 29.21%, 41.84%, 46.76%, and 51.41%, respectively) of patients into low-risk groups. Compared with the NICE, PROMISE, ESC, and CACS strategies, the CACS-CL strategy had a stronger association between risk groups and obstructive coronary artery disease (odd ratios: 16.00 vs 2.93, 5.53, 7.94, and 10.39, respectively), major adverse cardiovascular events (HRs: 6.83 vs 1.90, 2.94, 4.23, and 5.13, respectively) and intensive subsequent clinical management as well as better metrics of diagnostic accuracy and positive net reclassification improvement.

CONCLUSIONS: Among contemporary strategies used to identify patients with stable chest pain at low risk, the use of CACS, especially when combined with clinical risk features, showed the strongest potential to effectively defer cardiac testing.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Zhou J, Li C, Cong H, et al. Comparison of Different Investigation Strategies to Defer Cardiac Testing in Patients With Stable Chest Pain. JACC Cardiovasc Imaging. 2021. PMID: 34656487. doi:10.1016/j.jcmg.2021.08.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。